Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
US FDA ‘State Of Quality’ Report Targets Unreviewed, Uninspected Risks
May 16 2019
•
By
Bowman Cox
Uninspected facilities making unreviewed drugs have poorest quality, FDA finds.
More from Manufacturing
More from Compliance